Add to ORKG[[sponsorship]]細胞與個體生物學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0041-008X&DestApp=JCR&RQ=IF_CAT_BOXPLO
Abstract Purpose and Background: Acute promyelocystic leukemia is the most malignant acute leukemi...
Background and Aim: Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukem...
Neuroblastoma, characterized by heterogeneous cell population, is a common solid tumor in childhood ...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
none9noneG. Tabellini; P.L. Tazzari; R. Bortul; C. Evangelisti; A.M. Billi; T. Grafone; G. Martinell...
The present study investigates the molecular details of how arsenic trioxide inhibits preadipocyte d...
The majority of leukaemic cells are resistant to apoptosis induced by tumour necrosis factor-related...
Arsenic trioxide, the trade name Trisenox, is a drug used to treat acute promyleocytic leukemia (APL...
1. Arsenic trioxide (As2O3) has recently been used to treat acute promyelocytic leukaemia and has ac...
Introduction: Arsenic Trioxide (As2O3) causes antitumor effects by various mechanisms, including deg...
Two myelodysplastic syndrome (MDS) cell lines, MUTZ-1 and SKM-1 cells, were used to study the effect...
Arsenic trioxide (ATO) is a strong inducer of apoptosis in malignant hematological cells. Inducible ...
To investigate the mechanism of arsenic trioxide (As(2)O(3)) induced apoptosis in hepatic blastoma c...
Arsenic trioxide has been reported to inhibit cell growth and induce apoptotic cell death in many hu...
Arsenic trioxide (As2O3) exhibits potent antineoplastic effects and is used extensively in clinical ...
Abstract Purpose and Background: Acute promyelocystic leukemia is the most malignant acute leukemi...
Background and Aim: Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukem...
Neuroblastoma, characterized by heterogeneous cell population, is a common solid tumor in childhood ...
[[sponsorship]]生物醫學科學研究所[[note]]已出版;[SCI];有審查制度;具代表性[[note]]http://gateway.isiknowledge.com/gateway/...
none9noneG. Tabellini; P.L. Tazzari; R. Bortul; C. Evangelisti; A.M. Billi; T. Grafone; G. Martinell...
The present study investigates the molecular details of how arsenic trioxide inhibits preadipocyte d...
The majority of leukaemic cells are resistant to apoptosis induced by tumour necrosis factor-related...
Arsenic trioxide, the trade name Trisenox, is a drug used to treat acute promyleocytic leukemia (APL...
1. Arsenic trioxide (As2O3) has recently been used to treat acute promyelocytic leukaemia and has ac...
Introduction: Arsenic Trioxide (As2O3) causes antitumor effects by various mechanisms, including deg...
Two myelodysplastic syndrome (MDS) cell lines, MUTZ-1 and SKM-1 cells, were used to study the effect...
Arsenic trioxide (ATO) is a strong inducer of apoptosis in malignant hematological cells. Inducible ...
To investigate the mechanism of arsenic trioxide (As(2)O(3)) induced apoptosis in hepatic blastoma c...
Arsenic trioxide has been reported to inhibit cell growth and induce apoptotic cell death in many hu...
Arsenic trioxide (As2O3) exhibits potent antineoplastic effects and is used extensively in clinical ...
Abstract Purpose and Background: Acute promyelocystic leukemia is the most malignant acute leukemi...
Background and Aim: Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukem...
Neuroblastoma, characterized by heterogeneous cell population, is a common solid tumor in childhood ...